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Introduction
The cryopreservation of oocytes is valuable for the treat-
ment of infertility. Oocyte cryopreservation has wider
clinical implications than embryo freezing [1]. Women
who have no partner or are about to lose their ovarian
function because of surgery, chemotherapy or radio-
therapy could store their oocytes for future use [2–4].
It also provides an alternative to embryo preservation
to avoid ethical issues and legal restrictions [5]. For
patients undergoing in vitro fertilization, freezing the
excess oocytes could avert repeated oocyte retrieval
from the patients themselves or be a source for oocyte
donation [6]. This is especially important in countries
that authorize donation of oocytes, but not embryos,
to infertile couples.
Cryopreservation of human oocytes has been sig-
nificantly improved by both the slow-freezing methods
with increased sucrose concentration and new vitrifica-
tion techniques [7–11]. The slow-freezing method using
a programmed cryo-machine is traditionally employed
for the cryopreservation of oocytes [12]. These proce-
dures usually take several hours. Vitrification with higher
concentrations of cryoprotectants and a fast cooling
rate, it transforms cells into an amorphous glassy 
state without ice crystal formation [13]. Vitrification is
time-saving and does not require special equipment.
Minimum volume methods with less concentrated vit-
rification solution have replaced the conventional straw
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method [9–11,14,15]. The superiority regarding survival
of oocytes, effect on the meiotic spindles, and pregnancy
by the slow-freezing method or vitrification deserves
further investigation.
The Slow-freezing Method with 1.5M 
1,2-Propanediol (PROH) and 0.3M
Sucrose Increases Survival of Oocytes
Using the same freezing solution with 1.5M PROH 
and 0.1M sucrose of the slow method, mature human
oocytes had lower survival rates of 25–34% than do
embryos of 75–80% [16,17]. The cytoplasmic mem-
branes of oocytes, which have fewer submembranous
actin microfilaments, are more fragile to cryopreser-
vation [18]. The volume-to-surface ratio of oocytes is
greater, making the dehydration process more difficult.
Porcu et al [19] used the regime of 1.5M PROH with a
higher sucrose concentration of 0.2M and obtained a
59% post-thaw survival rate. Fabbri et al [7] showed
that increasing the sucrose concentration to 0.3M and
exposing oocytes for 15 minutes to cryoprotectants
yielded a higher oocyte survival rate of 82%. The regime
is thought to dehydrate the oocytes more adequately
and reduce intracellular ice formation.
Vitrification Leads to Significant
Improvement in the Survival of Oocytes
Another important method to improve the survival of
cryopreserved oocytes is vitrification. The recent improve-
ments for vitrification include the concepts of increase
of cooling and warming rates using minimum volume
methods and decrease of toxicity by reduction of con-
centration of cryoprotectants [20,21].
Minimum Volume Methods Replace
Conventional Straws for Vitrification
A 0.25-mL conventional straw was initially used for 
vitrification of oocytes. The cooling rate was around
2,500ºC/minute and the warming rate was 1,300ºC/
minute [13]. The limited speed of thermal change of
the conventional straw needs more concentrated cryo-
protectants to achieve vitrification during cooling and
to prevent devitrification during warming. The higher
concentrated cryoprotectants are more toxic to oocytes.
Using minimum volume methods, a higher cooling
rate can facilitate vitrification with less concentrated
cryoprotectants, and a higher warming rate will prevent
devitrification. In addition, the high speed of cooling
and warming of minimum volume methods can rapidly
pass through a damaging temperature zone liable for
chilling injury between 15ºC and −15ºC [22]. The chill-
ing injury harms mainly the cytoplasmic lipid droplets
and meiotic spindle of oocytes.
Landa and Tepla [23] performed vitrification by
dropping the mouse embryos directly into the liquid
nitrogen. But to form a drop needs a relatively large
amount of solution (approximately 5 μL). When the
drop reaches the liquid nitrogen, it will not sink imme-
diately but float on the surface for several seconds.
The drop leads to a strong evaporation at its surface
that decreases the cooling rate. Besides, it is difficult
to find the embryos for performing thawing.
Further improvements using various carriers to
minimize the volume of vitrification solution and to
submerge the sample swiftly into the liquid nitrogen
were broadly studied. Steponkus et al [24] first utilized
electron microscopic copper grids as a carrier for the
minimum volume–direct contact approach. They suc-
cessfully cryopreserved chill-sensitive Drosophila embryos
by vitrification. Martino et al [22] applied this tech-
nique for bovine oocytes, and achieved higher growth
potential than using conventional straws. Hong et al
[25] and Yoon et al [26] achieved successful pregnancies
from vitrified human oocytes using the grid method.
Arav [27] reported the other minimum drop size
method that a small droplet of vitrification solution
containing oocyte was placed on a thin glass surface.
That was then immersed into liquid nitrogen to achieve
vitrification. They observed that the minimum droplet
(0.5 μL) of less concentrated vitrification solution can
prevent ice crystal formation and fracture injury [28].
Vajta et al [29] developed open pulled straws (OPS)
to hold bovine oocytes with a small amount of vitrifi-
cation solution (1μL). The idea was to reduce the volume
of the sample using a pulled straw. The straws were
heated and pulled by hand, then cut at the tapering end.
As the result, the diameter and the wall thickness of the
straw decreased to approximately half of the original.
The cooling and warming rates are higher for OPS
(16,700°C/minute and 13,900°C/minute, respectively)
than the conventional straw. They found that OPS
achieved better results than conventional vitrification.
Kuleshova et al [30] applied OPS for vitrification of
human oocytes and achieved a successful pregnancy.
Lane et al [31] first used cryoloops (Cryoloop;
Hampton Research, Laguna Niguel, CA, USA) for vitrify-
ing human blastocysts. The device of a Cryoloop con-
sists of a small nylon loop attached to a holder and
equipped with a vial as a container. Oocytes or embryos
are suspended on a film of vitrification solution, bridging
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the hole of the loop that is then plunged into liquid
nitrogen. The size of droplet in the Cryoloop is limited
by this special design.
Vanderzwalmen et al [32] developed the hemi-
straw system in which the carrier was a cut open straw.
Kuwayama and Kato [33] developed the Cryotop
(Kitazato Supply Co., Fujinomiya, Japan) method using
a fine polypropylene strip for a minimum volume
method. With the Cryotop, the achievable cooling rate
and warming rate were significantly increased and were
23,000°C/minute and 42,100°C/minute, respectively
[34]. Chian et al [10] modified the Cryotop to be the
Cryoleaf (MediCult, Jyllinge, Denmark) with a different
way to apply the protection sheath. Both Cryotop and
Cryoleaf achieved a high success rate in vitrification of
human oocytes [9,10].
However, the direct contact system may have the
problem of potential contamination from liquid nitro-
gen. Chen et al [35] modified the loading of OPS to into
a closed system, called closed pulled straws (CPS). CPS
had the characteristics of OPS as a rapid thermal change
method, and of conventional straws as being a non-
contact mode. The vitrification medium containing
oocytes was isolated by two small segments of air and
medium. Through this closed loading system of CPS, the
oocytes will not directly contact with liquid nitrogen,
which may occur with OPS. Kuwayama et al [34] devel-
oped a Cryotip (Kitazato Supply Co., Fujinomiya, Japan)
method. Basically, it was a heat-sealed pulled straw
technique. The speed of cooling and warming was
smaller in Cryotip than Cryotop. But the thermal speed
accompanied by the Cryotip was still high enough to
obtain adequate vitrification. The use of the closed
system may eliminate the possible contamination. The
efficacy of CPS or Cryotip deserves further investigation.
Using Less Concentrated Cryoprotectants
for Vitrification Reduces Toxicity
Rall and Fahy [13] first successfully vitrified mouse eight-
cell embryos using conventional straws with the medium
consisting of 20.5% (w/v) dimethyl sulfoxide (DMSO),
15.5% (w/v) acetamide, and 10% (w/v) propylene glycol
and 6% (w/v) polyethylene glycol. The treatment of vit-
rification solution for embryos must be performed at a
low temperature of 4°C. Ali and Shelton [36] developed
an ethylene glycol (EG)-based vitrification solution
consisting of 5.5M EG and 1.0M sucrose for reducing
toxicity, which permitted the equilibration steps to be
performed at room temperature. Chen et al [14] used
this formulated solution for vitrification of human oocytes
and attained high survival rates by conventional straws.
EG, with the characteristics of low toxicity and rapid
permeation of the cell, is an important component of
vitrification solutions. Some authors mixed other per-
meating agents, such as DMSO or PROH, to reduce
the concentration of single cryoprotectant, which may
decrease the individual specific toxicity [10,37]. Non-
permeable cryoprotectants, such as sucrose, can facil-
itate dehydration and vitrification, which reduce the
required concentration of permeable cryoprotectants
[21]. Recently, the less concentrated vitrification solu-
tion consisting of 15% (v/v) EG, 15% (v/v) DMSO or
PROH, and 0.5M sucrose can be vitrified with the min-
imum volume method [10,37]. This strategy further
reduces the toxicity of vitrification solution.
Treatment of Cryoprotectants with
Stepwise Equilibration at Room
Temperature
Another important strategy to reduce toxic effects
from vitrification solution is the stepwise equilibration
of cryoprotectants. A two-step strategy is mainly used
[21]. The pretreatment solution contains 20–50% con-
centrations of cryoprotectants of the vitrification solu-
tion. The lower concentration of cryoprotectants in
the pretreatment solution is much less toxic than the
vitrification solution. Oocytes in the pretreatment solu-
tion shrink initially and gradually re-expand to their
original volume. This observation indicates the entry
of the permeating cryoprotectants into the oocytes. It
reduces the time needed for exposure to the subsequent
vitrification solution that is more toxic for oocytes. In
the vitrification of human oocytes, it has been demon-
strated that oocytes pretreated with equilibration solu-
tion had a significantly higher survival rate than those
without pretreatment [14]. One-step vitrification with-
out pretreatment has the possibility of insufficient per-
meation of the cryoprotectants, which may result in
intracellular ice formation during cooling or warming.
For oocyte vitrification, some investigators perform
exposure to cryoprotectants at room temperature [9,
10,14], but other investigators operate the procedures
at 35–37°C [26,29]. The higher temperature enhances
the passage of the permeating cryoprotectants across the
cell membrane, but the toxicity is also increased. There-
fore, at 37°C, 2–3 minutes are used for the pretreat-
ment solution, and 20–30 seconds are exposed for the
vitrification solution [26,29]. In contrast, at room tem-
perature, 5–15 minutes are used for the pretreatment
solution, and 30–60 seconds are exposed for the vitri-
fication solution [9,10,14]. Prolonged exposure to the
concentrated cryoprotectants may induce a toxic effect.
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The human oocytes treated in vitrification solution for
120 seconds had a poorer fertilization outcome than
those vitrified in 60 seconds [14].
Warming at 37ºC with Stepwise 
Dilution
The speed of warming is important to prevent devitrifi-
cation. Minimum volume methods, such as electron
microscopic grid, Cryoloop or Cryotop, can be directly
submerged into the dilution medium. The oocytes con-
tact with the dilution medium immediately. The vitrified
oocyte is sensitive to osmotic changes after warming.
A stepwise dilution with sucrose medium as osmotic
buffer is commonly used to prevent excessive swelling
as the permeating cryoprotectants leave. Most investi-
gators performed warming at 37ºC and dilution at
room temperature [11,15]. Dilution at 37ºC may lessen
spindle damage during the procedures, which deserves
further study [38]. Two-to-three step dilutions with
sucrose solutions were usually used, and the effects
may merit further investigation.
The Cryotop Method for Vitrification of
Oocytes
The Cryotop developed by Kuwayama and Kato [33] 
is now commonly used as a carrier for vitrification of
oocytes, and the procedures are described as follows.
Oocytes were equilibrated in 7.5% (v/v) EG and 7.5%
DMSO in TCM199 (tissue culture medium 199) medium
with 20% synthetic serum substitute at room tempera-
ture for 15 minutes. They were then placed into vitrifi-
cation solution of 15% EG and 15% DMSO with 0.5M
sucrose. After 1 minute in this solution, oocytes were
placed on the Cryotop. The Cryotop has a fine polypro-
pylene strip (0.4 mm wide ×20 mm long ×0.1 mm thick)
(Kitazato Supply Co., Fujinomiya, Japan) attached to
a plastic holder and equipped with a protective plastic
tube [9]. Oocytes are loaded on the strip with minimal
solution (0.1 μL), and the solution is further almost
completely removed by aspiration. The Cryotop is im-
mersed into filtered liquid nitrogen. Then, the strip is cov-
ered with the plastic tube in liquid nitrogen to protect it
during storage. For warming, the protective cover is
removed from the Cryotop while it is still submerged in
liquid nitrogen. The strip is immersed directly into the
dilution solution of 1.0M sucrose solution for 1 minute
at 37ºC. The thawed oocytes were transferred to 0.5M
and 0.25M sucrose solutions for 3 minutes at room tem-
perature, and then washed twice with culture medium.
Liquid Nitrogen Slush Increases Cooling
Rate but Not Warming Rate
For enhancing the cooling rate and vitrification, one
approach is to employ liquid nitrogen slush instead of
liquid nitrogen. Nitrogen slush can be produced from
liquid nitrogen by using vacuum, in which part of 
the liquid nitrogen evaporates and the rest of it cools
down. The mixture of nitrogen slush and cooled liquid
nitrogen is cooled to −205°C. It is commercially avail-
able with the construction of the Vit-Master (IMT,
Israel) [39]. The concentration of cryoprotectants may
be lowered using liquid nitrogen slush, which merits
further study. However, the speed of warming may not
be changed to prevent devitrification. Besides, most
investigators achieve satisfactory results of vitrification
of human oocytes using liquid nitrogen only [9–11].
Nonetheless, Cai et al [40] found that the faster cool-
ing rate with Vit-Master had fewer adverse effects on
the spindle configuration of vitrified rabbit oocytes
than using liquid nitrogen only. The superiority of the
Vit-Master compared with liquid nitrogen only still
needs further elucidation.
Injury and Recovery of Meiotic Spindles of
Frozen–Thawed Oocytes from Slow
Freezing or Vitrification
The meiotic spindles of oocytes consist of microtubules
that are constructed by polymerization of tubulin dim-
mers of α- and β-tubulin. Microtubules start from micro-
tubular organizing centers at both poles and anchor
chromosomes at the kinetochores. The chromosomes
align at the equatorial plane of the meiotic spindles.
The tubulin dimmer would polymerize and depolymer-
ize at various stages of a cell cycle. The meiotic spindles
are crucial for the events following fertilization in the
completion of meiosis, second polar body formation,
migration of the pronuclei, and formation of the first
mitotic spindle [41].
The spindle is very sensitive to cryoprotectants and
low temperature. Oocytes analyzed immediately after
thawing displayed severe disorganization or disappear-
ance of spindles using slow or vitrification methods
[35,42,43]. Incubation for 1–3 hours at 37ºC resulted
in recovery of spindles in various degrees, which were
dependent on time intervals after thawing and the
freezing methods (Table 1).
In vitrified mouse oocytes, Chen et al [43] observed
that post-thawing incubation for 1 hour allowed re-
covery of normal spindle and chromosomes to diverse
degrees. The OPS, CPS, and electron microscopic grids
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preserved the spindle morphology and chromosomal
pattern better than conventional straws. The rapid ther-
mal change of minimum volume methods may quickly
traverse the temperature that is damaging to the spindle,
assumed to be 15ºC to −15ºC [22]. Moreover, oocytes
of minimum volume methods are directly warmed in
the dilution solution and immediately diluted. This
reduces exposure of oocytes to inappropriate temper-
atures and concentrated cryoprotectants [21]. Chen
et al [35] further demonstrated that incubation for 
2 or 3 hours resulted in higher percentages of normal
spindles than 1 hour. Morato et al [44] found that 
cryotops achieved better spindle preservation than
OPS for vitrification of bovine oocytes.
For human oocytes with slow cryopreservation,
Gook et al [18] noticed that 60% of oocytes were com-
posed of normal spindles at 1 hour of incubation after
thawing, compared with the control specimens of 81%.
Using a computer-assisted polarization microscopy
(PolScope, SpindleView; CRi, Woburn, MA, USA), Rienzi
et al [45] observed the disappearance of the spindle in
all of the oocytes after thawing and washing. The spindle
reappeared by 3 hours of incubation. Coticchio et al
[46] found that spindles were significantly affected after
the slow-freezing method using 0.1M sucrose concentra-
tion, while they were unchanged using the 0.3M sucrose
protocol. Ciotti et al [38] reported that spindle recovery
was faster in vitrification than in slow freezing. Cobo
et al [15] found comparable spindle recovery from vit-
rification and slow freezing after 3 hours of incubation.
Time Schedule for Freezing/Thawing
Oocytes and Fertilization: Considering
Both Aspects of Spindle Recovery and
Oocyte Aging
The changes and recovery of the spindles from freezing
and thawing have been linked to the functional effects
of oocytes on fertilization and development [35,42].
Eroglu et al [42] observed that slowly cryopreserved
mouse oocytes inseminated immediately after thawing
exhibited impairment of the spindle rotation, second
polar body formation, and an increased rate of digyny.
Chen et al [35] found that the percentages of fertiliza-
tion and blastocyst formation of vitrified mouse oocytes
inseminated immediately or at 1 hour of incubation
were significantly lower than those of the control spec-
imens, but they were improved when inseminated at 
2 or 3 hours of incubation.
The mature oocyte maintains at the metaphase of
meiosis II with organized spindle system. After fertil-
ization by entry of a spermatozoon, the intracellular
calcium increases and the cytostatic factors decrease
[47]. The oocyte completes meiosis II and extrudes the
second polar body. The mature oocyte must be fertilized
at the adequate time. Otherwise, it will undergo apo-
ptosis. Delayed insemination of mature oocytes results
in compromised embryos [48]. Dozortsev et al [49]
observed that the optimal time of intracytoplasmic
sperm injection (ICSI) for human oocytes was from 37
to 41 hours after administration of human chorionic
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Table 1. Effect of various methods of cryopreservation on the meiotic spindles of oocytes and their recovery
Freezing methods Oocytes Examination Results Authors
Vitrification Mouse Immunostain OPS preserve better spindle than Chen et al [43]
conventional straws
Vitrification Mouse Immunostain After 2 or 3 hr of incubation, the spindle Chen et al [35]
patterns significantly better than 1 hr
Vitrification Bovine Immunostain Cryotops preserve better spindle than OPS Morato et al [44]
Slow Human Immunostain 60% thawed oocytes with normal spindles Gook et al [18]
after 1 hr of incubation, 81% for controls
Slow Human Polscope Spindle disappeared after thawing, but all Rienzi et al [45]
reappeared by 3 hr of incubation
Slow Human Immunostain 0.3M sucrose in the freezing solution Coticchio et al [46]
preserves spindle better than 0.1M
Vitrification vs. Human Polscope Spindle recovery faster in vitrification than in Ciotti et al [38]
slow slow freezing
Vitrification vs. Human Immunostain After 3 hr of incubation, comparable spindle Cobo et al [15]
slow recovery from vitrification and slow freezing
OPS = open pulled straws.
gonadotropin (hCG). Those fertilized oocytes achieved
the highest implantation rate.
Therefore, choosing the optimum time for fertiliza-
tion, considering both aspects of spindle recovery and
oocyte aging, is important for a successful oocyte cryo-
preservation program. The oocyte retrieval is usually
performed 35 hours post-hCG. Cryopreservation of
oocytes is performed at 2 hours after oocyte retrieval.
For the slow-freezing protocol, the equilibration time
before freezing and the dilution time after thawing take
approximately 1 hour. ICSI is performed at 3 hours
post-thaw (post-hCG 41 hours) [1,8]. For the vitrifica-
tion method, the equilibration and dilution is around
10 minutes, which could be negligible. ICSI is usually
performed at 2 hours post-thaw (post-hCG 39 hours)
[11,15]. Therefore, the timing of insemination for
frozen–thawed oocytes is in an optimal interval.
Superiority of the Slow-freezing Method
or Vitrification
The slow-freezing method with a higher concentration of
sucrose (0.3M) or minimum volume vitrification using
Cryotop or Cryoleaf with less concentrated vitrification
solution has been mainly used in in vitro fertilization
centers. We reviewed the results of the two methods
reported in the recent literature, which are summa-
rized in Table 2. The survival of cryopreserved oocytes
using the slow-freezing method ranged from 74% to
90% [5,6,8,50,51] and ranged from 84% to 99% for
the vitrification method [9–11,15,52]. Overall, the sur-
vival rate of oocytes from vitrification (95%, 899/948)
appeared greater than that of the slow-freezing method
(75%, 1,275/1,683). The pregnancy rate ranged from
9% to 75% for the slow-freezing method and 33% to
57% for vitrification. However, the case number was
small in most of the series. There are still no prospec-
tive randomized control studies to compare the sur-
vival, implantation potential and pregnancy rates of
these two methods, which may deserve further investi-
gation [53].
Comparable Results of Cryopreserved
Oocytes to Fresh Oocytes and 
Frozen Embryos
In our center, we use the protocol of 1.5M PROH and
0.1M sucrose for cryopreservation of pronuclear or
2–8-cell embryos [54]. The embryos cryopreserved at
the pronuclear stage were randomly allocated, unlike
those at the cleavage stage which are usually frozen
after selection for fresh transfer of those with better
morphology. The percentages for survival, pregnancy
and implantation for frozen–thawed pronuclear embryos
were similar to those of frozen–thawed oocytes [8].
These findings were consistent with the results from
Boldt et al [55]. In addition, Yang et al [56] found that
the outcome parameters from thawed oocytes and
embryos derived from sibling oocytes were also similar.
Recently, Cobo et al [15] reported that oocyte vitrifica-
tion provides a similar pregnancy rate to that obtained
using fresh oocytes.
Conclusion
Significant improvement of cryopreservation of oocytes
has been achieved by both slow freezing and vitrification.
The minimum volume vitrification facilitates increase
of cooling and warming rates, reduction of concentra-
tion of cryoprotectants, and recovery of meiotic spin-
dle. Vitrification appears to have a higher survival rate
than slow freezing. Considering the effects of both oocyte
aging and spindle recovery, the proposed time schedule
for oocyte cryopreservation program allows for fertiliza-
tion in the optimal time. Because of comparable survival
and pregnancy rates, oocyte freezing provides an alter-
native to embryo freezing for couples with religious or
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Table 2. Survival and clinical pregnancy of cryopreserved oocytes from slow freezing (0.3M sucrose) and vitrification 
(Cryotop or Cryoleaf)*
Slow freezing Vitrification†
Survival Pregnancy Authors Survival Pregnancy Authors
119/159 (75) 7/21 (33) Chen et al [8] 58/64 (90) 12/29 (41) Kuwayama et al [9]
73/81 (90) 7/15 (47) Li et al [6] 169/180 (94) 7/15 (47) Chian et al [10]
687/927 (74) 18/201 (9) Borini et al [50] 120/143 (84) 13/23 (57) Lucena et al [11]
68/79 (86) 3/4 (75) Barritt et al [51] 328/330 (99) 39/120 (33) Antinori et al [52]
328/437 (75) 16/83 (19) Parmegiani et al [5] 224/231 (97) 11/23 (48) Cobo et al [15]
*Data are presented as n (%); †Chian et al [10] used Cryoleaf, and the other authors used Cryotop.
ethical concerns. Cryopreservation of oocytes would
meaningfully contribute to oocyte donation and pre-
servation of fertility in patients about to lose ovarian
function.
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